Greetings!
Welcome to the March 2012 edition of our Discover More newsletter.
We will be sponsoring and attending 3 major conferences this year which will be held in Nantes (France), Washington DC (USA), and Dublin (Ireland). We look forward to seeing you there!

In our featured client spotlight is Metabolomic Technologies Inc, a private company pioneering a non-invasive, rapid and accurate screening test for colorectal cancer and polyps using metabolomics and spectral analysis services from Chenomx!

Our publications list has been updated with over 100 new articles referencing our software in 2011. Be sure to check them out!

In February, Chenomx 7.5 was released with useful new functions. You can read about the highlights below!
Come Out and Meet Us at Conferences!
RFMF French Metabolomic and Fluxomic Network - May 21-23, 2012
Chenomx has been invited to Nantes in France this year and will be sponsoring and attending their event. This event brings together all those in France who contribute to the development of Metabolomics and Fluxomics, and to the overall analysis of metabolism in France. The RFMF facilitates relationships between researchers, and ensures their representation in national and international organizations. More Info

Metabolomics Society 2012 Meeting
- June 25-28, 2012
Chenomx will be sponsoring and attending the annual Metabolomics Society Meeting in Washington DC this year. This meeting brings together metabolomics researchers from around the world to discuss their most recent achievements in the field of metabolomics. More Info

Euromar 2012 - July 1-5, 2012

Chenomx will be sponsoring and attending Euromar this year in Dublin Ireland. Euromar is a well-established annual international conference on Magnetic Resonance attended by Nobel Laureates, leading scientists, world-renowned commercial partners, and companies in the area of nuclear magnetic resonance research and applications. More Info  

Publications and Resources
Our publications list has been updated with over 100 new articles referencing our software in 2011. Research that has used our software includes metabolomics, medical and clinical studies, toxicology, microbiology, physiology environmental, plant biology, and food biology. See the full list here. If you have a publication referencing our software not found in the list please let us know and we can add it!

We also have useful application notes which outlines various techniques and approaches that are related to using our software and can be found here.
 
Chenomx 7.5 Highlights and Tips

We released version 7.5 in February and highlights of new features in 7.5 include: 

 

Improved Image Export:

Exporting images for publications or presentations is easier than ever. Options for both raster formats with customizable sizes, and vector formats with bolder graph lines are available. The software will guide you to the best choice in graphical formats based on your final document needs. 

 

Structural Assignments in Reference Panel:

The Reference Panel now contains structural assignments for each cluster found in the Chenomx Reference Compounds. Use this information for more confident metabolite assignments, or to infer potentially similar structures.  These compound structures can still be copied into the system clipboard.

 

Automatic Coloring of Spectrum Lines:

Chenomx NMR Suite can now automatically assign different colors to groups of spectrum lines on the graph, including overlays or pinned compound lines.

 

Multiple Compound Selections:

You can now select and perform functions in the Profiler Compound menu on multiple compounds. This allows more efficient analysis of spectra obtained from sample sets and drastically reduces the time required for targeted profiling.

 

Fit Multiple Compounds Automatically:

We've redesigned this feature to work more intuitively with the Multiple Compound Selection feature. Just select the compounds you wish to autofit, and then run the Fit Automatically feature. Once you have identified the metabolites in one spectrum, you can group and autofit the same metabolites in the rest of the spectra quickly and efficiently reducing the need to autofit the same compounds one by one on each spectrum.

 

For more information please go here

If you have any questions or comments please direct them to:

Albert Leung
info@chenomx.com
(780) 432-0033 ext. 2228
Chenomx Inc. 
Chenomx
Featured Client - Metabolomic Technologies Inc

Dr. Fedorak and his colleagues released a study last year which looks at healthy people, people with benign colon polyps which usually don't develop into cancer, and people with polyps which are considered pre-cancerous growths that could become cancerous.

 

Using metabolomics and spectral analysis services from Chenomx, Dr. Fedorak discovered that unique chemical fingerprints of certain metabolites in a person's urine are indicative of colon cancer.

The urine test was over 80 per cent effective at spotting the cancer as well as pre-cancerous growths, which is similar to colonoscopies. You can read the full article and view the video here.
Quick Links

Join Our Mailing List